NCT04338997View on ClinicalTrials.gov

PK Study in Patients With Parkinson's Disease With IZD174

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

December 31, 2020

Conditions
Parkinson Disease
Interventions
DRUG

IZD174

Small molecule inhibitor of NLRP3

Sponsors

Lead Sponsor

Inflazome UK Ltd
All Listed Sponsors
lead

Inflazome UK Ltd

INDUSTRY